Analyst Report

Media Center

Press Coverage Analyst Report FAQ IR Inquiry

Analyst Report
번호	제목
12	Daishin Securities_Cellbion_Entering Commercialization Stage for Korea∙∙∙	2026.06.25
11	Bookook Securities_Cellbion_Abundant Momentum in Q2∙∙∙	2026.04.06
10	Hana Securities_Cellbion_CSR Report Receipt, Conditional Approval Appl∙∙∙	2025.12.15
9	SK Securities_Cellbion_CSR Disclosure, Dispelling Uncertainty with Dat∙∙∙	2025.12.15
8	Sangsangin Securities_Cellbion_Paying Attention to the Commercializati∙∙∙	2025.12.08
7	SK Securities_Cellbion_Dreaming of the Next Pluvicto∙∙∙	2025.12.02
6	SK Securities_Cellbion_Excessive Stock Price Drop, Paying Attention to∙∙∙	2025.10.29
5	Bookook Securities_Cellbion_Superiority over Pluvicto Confirmed, Initi∙∙∙	2025.09.22
4	Sangsangin Securities_Cellbion_Developing a Radiopharmaceutical for Pr∙∙∙	2025.08.25
3	Shinyoung Securities_Cellbion_Will It Become a Frontrunner in Radiopha∙∙∙	2025.08.12
2	KB Securities_Cellbion_Dark Horse in the Radiopharmaceutical Field∙∙∙	2025.07.09
1	Hanyang Securities_Cellbion_Strong Player in Radiopharmaceuticals∙∙∙	2025.07.05

LIST